Medigene Immunotherapies

WIPO WIPO 2021

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark Medigene Immunotherapies was filed as Word mark on 02/23/2021 at the World Intellectual Property Organization.

Trademark Details Last update: April 17, 2023

Trademark form Word mark
File reference 1587277
Countries China Japan United States of America (USA)
Base trademark EU No. 018327910, October 28, 2020
Application date February 23, 2021
Expiration date February 23, 2031

Trademark owner

Lochhamerstr. 11
82152 Planegg-Martinsried
DE

Trademark representatives

Josephspitalstr. 15 80331 Munich DE

goods and services

01 Nucleic acids
05 Medicines for humans and animals, vaccines, serums, test kits and diagnostic preparations, in particular manufactured using molecular biological, genetic engineering and biotechnological methods; proteins, cell products, protein conjugates, peptides, enzymes and enzyme preparations, in particular antibodies and t-cell proteins; t-cells, dendritic cells and other immune system cells, viruses and particles similar to viruses; liposomes; plant extracts; low-molecular active substances; medicines, vaccines, adjuvants, serums, test kits and diagnostic agents relating to precancerous cells, benign and malignant tumours, in particular haematological tumours, inflammatory disorders, neurodegenerative disorders, autoimmune conditions and immunotherapy
42 Molecular biology and biotechnology laboratory services, in particular research and development in the field of medical and veterinary diagnosis and treatment using molecular biological, genetic engineering and biotechnological methods, and in the field of screening for pharmaceutically active components; development of test procedures and test kits in the field of biotechnology and medicine
44 Medical analysis and medical consulting in connection with the treatment of individuals, in particular in the field of precancerous cells, benign and malignant tumours, autoimmune diseases and immunotherapy
45 Licensing of intellectual property, including trademarks and patents in the field of biotechnology, pharmacy and medicine

Trademark history

Date Document number Area Entry
April 6, 2023 2023/15 Gaz US RAW: Rule 18ter(2)(ii) GP following a provisional refusal
August 4, 2022 2022/32 Gaz JP RAW: Rule 18ter(2)(ii) GP following a provisional refusal
February 17, 2022 2022/7 Gaz JP Rejection
October 1, 2021 2021/40 Gaz US Rejection
September 2, 2021 2021/37 Gaz CN Rejection
February 23, 2021 2021/14 Gaz EM Registration

ID: 141587277